Answers are grounded in this paper and cite their sources.
Administering additional cladribine courses is an effective option to maintain disease control and did not trigger any serious adverse events attributable to the therapy. Patients with elevated serum transaminase levels should be regularly monitored.
No takes yet. Share an insight, caveat, or question.
Kleinschnitz et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: